ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1902

Improving the Sharing of Information from Reviews of Measurement Properties: The OMERACT Summary of Measurement Properties (SOMP) Table

shawna grosskleg1, lara maxwell2, Dorcas Beaton3, B Shea1 and Peter Tugwell1, 1OMERACT, Ottawa, ON, Canada, 2University of Ottawa, Ottawa, ON, Canada, 3Institute for Work & Health, Toronto, ON, Canada

Meeting: ACR Convergence 2023

Keywords: Measurement, Measurement Instrument, OMERACT, Outcome measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1895–1912) Measures & Measurement of Healthcare Quality Poster II

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Systematic reviews of measurement properties of an outcome measurement instrument are fast becoming the evidence base for making decisions about the suitability of the instrument for a given application. Transparency in processes and decision-making at each step are important to allow consumers of the reviews to have a clear understanding of the results.At OMERACT (Outcome Measures in Rheumatology) we used an iterative process between methodologists and users for developing a summary of measurement properties table (SOMP) to use as a knowledge translation tool for communicating what was done, what was found, and what recommendations can be made from it.

Methods: Working with key stakeholders and end users, including patients, clinical trialists, clinicians and methodologists across several disease areas, the information that needed to be included in a SOMP was determined and initial designs laid out. Users provided feedback and revisions, which were integrated while ensuring the core elements were also being communicated.

Results: Several features emerged for inclusion in the SOMP.We wanted the SOMP to be a standalone resource so the name/version of the tool, the target population (if restricted in the review) and the target concept the reviewers are trying to measure with this instrument were all included at the top of the table. Further, we designed the SOMP to be assembled as teams moved through the review steps so that it was clear the level of detail that was going into any statement about an instrument, and it was transparent exactly which studies/primary resources were included in the review and how they were reviewed.

The SOMP (Figure 1) uses symbols (colour for critical appraisal of methods, +/- for comparison of results to psychometric standards) and algorithms (for making conclusions based on the results in the synthesis steps).Should steps not be done in a given review (i.e., no critical appraisal in a descriptive review) the absence of colours in the boxes would demonstrate this for the users. Rows within the table include evidence from each study included in decision-making.

Conclusion: The SOMP was designed to capture the measurement properties evidence and decision-making processes for the OMERACT community to agree on whether an instrument is good enough to be included to represent a domain for a core outcome set.Its iterative development within a multidisciplinary consensus-based organization has helped us develop a tool we are finding useful in the transparent communication about methods and decision-making made in a given review.Although our key target is regulatory approval and core outcome set development, we have learned about the importance of being transparent in how decisions were made about an instrument, and how to share the body of evidence with others, leading to broader applications of the evidence base.

Supporting image 1

OMERACT Summary of Measurement Properties (SOMP)


Disclosures: s. grosskleg: None; l. maxwell: None; D. Beaton: None; B. Shea: None; P. Tugwell: None.

To cite this abstract in AMA style:

grosskleg s, maxwell l, Beaton D, Shea B, Tugwell P. Improving the Sharing of Information from Reviews of Measurement Properties: The OMERACT Summary of Measurement Properties (SOMP) Table [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/improving-the-sharing-of-information-from-reviews-of-measurement-properties-the-omeract-summary-of-measurement-properties-somp-table/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-the-sharing-of-information-from-reviews-of-measurement-properties-the-omeract-summary-of-measurement-properties-somp-table/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology